🇺🇸 FDA
Pipeline program

ION717

ION717-CS2

Phase 2 small_molecule active

Quick answer

ION717 for Prion Disease is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Prion Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials